These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7077931)

  • 1. [Pharmacokinetic characteristics of trimecaine compared to lidocaine in myocardial infarct patients].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Metelitsa VI
    Kardiologiia; 1982 Apr; 22(4):62-5. PubMed ID: 7077931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative clinical study of trimecaine and lidocaine as anti-arrhythmia agents in myocardial infarct].
    Riabokon' OS; Piotrovskiĭ VK; Smirnova EB; Metelitsa VI; Mazur NA
    Kardiologiia; 1980 Oct; 20(10):40-2. PubMed ID: 6160280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative clinical study of the effectiveness of the new anti-arrhythmia agents, trimecaine and pyrromecaine].
    Pavlova TS; Riabokon' OS; Ivanova LA; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):67-72. PubMed ID: 6196040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of ventricular fibrillation using lidocaine in the acute period of a myocardial infarct].
    Mazur NA; Riabokon' OS; Banshchikov GT
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):59-64. PubMed ID: 6182894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic efficacy of trimecaine in cardiac rhythm disorders and ways of improving it].
    Tatarchenko IP; Oleĭnikov VE; Zhivotovskaia GG; Malinovskaia LI
    Kardiologiia; 1984 Dec; 24(12):51-5. PubMed ID: 6084095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lidocaine elimination and dose adjustment in acute heart infarct and heart insufficiency].
    Kettner W; Banditt P; Walther H
    Z Gesamte Inn Med; 1984 Jul; 39(14):335-42. PubMed ID: 6485432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative characteristics of the antiarrhythmic activity of lidocaine, trimecaine and pyromecaine].
    Orlov VM; Ivashchuk AG; Iartsev SS; Meshcheriakova NK; Tkhu FT
    Sov Med; 1984; (3):82-4. PubMed ID: 6719244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical pharmacokinetics and hemodynamics of ethacizin in the acute period of myocardial infarct].
    Beloborodov VL; Klimov AV; Tiukavkina NA; Kaverina NV; Pokazeeva ET
    Farmakol Toksikol; 1986; 49(5):32-6. PubMed ID: 3770172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The antiarrhythmic activity of the trimecain ammonium derivative in myocardial ischemia].
    Kostin IaV; Blinov DS; Moiseeva IIa
    Eksp Klin Farmakol; 2003; 66(3):29-31. PubMed ID: 12924229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lidocaine pharmacokinetics and substantiation of the new method of its administration in myocardial infarct].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Mazur NA; Metelitsa VI
    Kardiologiia; 1979 Jul; 19(7):23-7. PubMed ID: 470315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
    Vinçon G; Ploux D; Pehourcq F; Albin H
    J Pharmacol; 1983; 14(1):47-55. PubMed ID: 6834851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transplacental transport of trimecaine during the management of labor under prolonged peridural anesthesia].
    Babaev VA
    Akush Ginekol (Mosk); 1980 Dec; (12):16-9. PubMed ID: 7212192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Possibility of using trimecaine for the treatment of cardiac rhythm disorders in myocardial infarct].
    Poliskiĭ NM; Berger EI; Kotliarskaia LA; Voskoboĭnik LE; Kisel' SS
    Kardiologiia; 1979 Jul; 19(7):59-62. PubMed ID: 89217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effect of mesocaine and ajmaline in acute myocardial infarct].
    Vítovec J; Chaloupka V
    Vnitr Lek; 1979 Jul; 25(7):641-5. PubMed ID: 494498
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of the determination of lidocaine and anti-arrhythmic drugs in acute myocardial infarct].
    Matta F; De Marchi M; Pecchio F; Bevilacqua R; Aillon A; Piccinino C; Riva L; Alvino A; Angelino PF
    Minerva Cardioangiol; 1981 Apr; 29(4):131-6. PubMed ID: 7242944
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mesocaine levels in plasma after intramuscular and intravenous administration].
    Skalický J; Kubelková J; Jadrný L; Melichar J
    Vnitr Lek; 1981 Sep; 27(9):838-44. PubMed ID: 7293028
    [No Abstract]   [Full Text] [Related]  

  • 17. Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties.
    Levy RH; Smith GH
    Am J Hosp Pharm; 1973 May; 30(5):398-404. PubMed ID: 4704419
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lidocaine pharmacokinetics when administered intramuscularly].
    Piotrovskiĭ VK; Smirnova EB; Riabokon' OS; Metelitsa VI
    Farmakol Toksikol; 1980; 43(4):411-6. PubMed ID: 7439378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies of the antiarrhythmic activity of prolonged action quaternary ammonium derivatives of trimecaine (G-104) and lidocaine (QX-572)].
    Kostin IaV; Fillipov AK; Grenader AK; Gendenshteĭn EI; Porotikov VI
    Farmakol Toksikol; 1987; 50(6):45-7. PubMed ID: 3436423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of trimecaine, a new anti-arrhythmia agent].
    Gendenshteĭn EI; Ganelina IE; Kostin IaV; Kukuĭ LM; Tsybusov AP
    Klin Med (Mosk); 1980 Jun; 58(6):47-50. PubMed ID: 7401603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.